- Home
- MUFG vs PFE Comparison
MUFG vs PFE Comparison
Compare MUFG & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MUFG | PFE |
|---|---|---|
| Founded | 1880 | 1849 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.9B | 145.4B |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | MUFG | PFE |
|---|---|---|
| Price | $16.25 | $26.03 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $28.30 |
| AVG Volume (30 Days) | 4.3M | ★ 72.3M |
| Earning Date | 11-14-2025 | 11-04-2025 |
| Dividend Yield | 1.33% | ★ 6.61% |
| EPS Growth | N/A | ★ 131.89 |
| EPS | 0.76 | ★ 1.73 |
| Revenue | $38,565,096,137.00 | ★ $62,785,000,000.00 |
| Revenue This Year | $2.23 | N/A |
| Revenue Next Year | $7.31 | N/A |
| P/E Ratio | $21.03 | ★ $15.13 |
| Revenue Growth | N/A | ★ 3.89 |
| 52 Week Low | $10.46 | $20.92 |
| 52 Week High | $16.39 | $27.69 |
Technical Indicators
Market Signals| Indicator | MUFG | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 64.94 | 60.05 |
| Support Level | $15.63 | $25.04 |
| Resistance Level | $16.39 | $25.89 |
| Average True Range (ATR) | 0.25 | 0.54 |
| MACD | 0.08 | 0.06 |
| Stochastic Oscillator | 90.43 | 94.84 |
Price Performance
Historical ComparisonAbout MUFG Mitsubishi UFJ Financial Group Inc.
Mitsubishi UFJ Financial Group is the largest bank in Japan in terms of market capitalization and assets, with an 8.4% share of all domestic loans as of March 2025. It is the largest non-Chinese bank group globally and has a balance sheet slightly larger than those of JPMorgan Chase and HSBC Holdings. MUFG's operations in Japan account for around half of profit, banking in Thailand and Indonesia for around 15%, and equity-method earnings from Morgan Stanley most of the rest.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.